Technical analysis of PolyPid Ltd. (PYPD): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials.
Price Performance
| 1 month | +10.15% |
| 3 months | +9.92% |
| Year-to-date | +20.05% |
| 1 year | +54.60% |
| 3 years | -22.12% |
| 5 years | -97.77% |
52-Week Range
| 52-week High | $5.73 |
| 52-week Low | $3.06 |
| Avg Volume (90d) | 193K |
Technical Indicators
| SMA 50 | $4.87 |
| SMA 200 | $4.56 |
| Beta | 1.46 |
| 30-day Volatility (annualised) | 33.3% |
| Price vs SMA 50 | +7.0% |
| Price vs SMA 200 | +14.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $3.83 | |
| 2025-11 | $3.95 | +3.1% |
| 2025-12 | $4.34 | +9.9% |
| 2026-01 | $4.58 | +5.5% |
| 2026-02 | $4.25 | -7.2% |
| 2026-03 | $4.38 | +3.1% |
| 2026-04 | $4.50 | +2.7% |
| 2026-05 | $4.72 | +4.9% |
| 2026-06 | $5.08 | +7.6% |
| 2026-07 | $4.29 | -15.6% |
| 2026-08 | $5.14 | +19.8% |
| 2026-09 | $5.21 | +1.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | $563M |
| 2026-09-14 | | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $0.20 | $23M |
| 2026-09-14 | | |
Price
| Price | $5.21 |
| Market Cap | $99M |
| Exchange | NASDAQ |
| Country | IL |
Valuation Ratios
| Price / Book | 21.89 |
| EV / EBITDA | -3.18 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.29 |
| Current Ratio | 1.35 |